跳至主要内容
临床试验/NCT04012216
NCT04012216已完成不适用

Sleep Respiratory Disorders in Patients With Moderate to Severe Persistent Rhinitis: a Prospective, Predictive Study

University Hospital, Montpellier1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2020年1月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
55
试验地点
1
主要终点
The mandibular movement respiratory disturbance index

研究概览

简要总结

The general aim of this study is to demonstrate that the measurement of respiratory effort assessed by mandibular movements during sleep is a useful measure for the screening of sleep disordered breathing (SDB) in patients with moderate to severe persistent rhinitis (R). The primary objective is therefore to determine a mandibular movement respiratory disturbance index (MM-RDI) threshold associated with a polysomnography respiratory disturbance index (PSG-RDI) ≥ 15 / h in a population of patients with moderate-to-severe persistent R.

详细描述

The secondary objectives of the study are to evaluate the concordance and correlation between:

  • MM-RDI,
  • the respiratory effort evaluated by MM,
  • polysomnography (PSG) results,
  • quality of life questionnaires,
  • clinical data,
  • treatments.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient consulting for persistant, moderate-to-severe rhinitis
  • The patient has signed the informed consent
  • The patient is a beneficiary of a social security programme (national health insurance)
  • Patient living in the Montpellier region (< 30 kilometers).

排除标准

  • The patient is participating in another study that precludes participation in the present study
  • The patient is in an exclusion period determined by another study
  • It is impossible to correctly inform the patient
  • The patient cannot fluently read French
  • Vulnerable patient populations according to French Health Code article L1121-6
  • Adult under guardianship or incapable of giving consent according to French Health Code article L1121-8
  • Pregnancy, breastfeeding (French Health Code article L1121-5)
  • Any element that renders participation in the study problematic according to the investigator

结局指标

主要结局

The mandibular movement respiratory disturbance index

时间窗: Day 7

The polysomnography respiratory disturbance index

时间窗: Day 7

次要结局

  • Wake During Sleep Period(Day 7)
  • Signal validity(Day 7)
  • Forced vital capacity, % predicted(Day 1)
  • Patient reports presence/absence of concentration difficulty(Day 1)
  • The autonomy dimension of the EQ-5D-3L Questionaire (the 3-level version of Euroqol EQ-5D)(Day 1)
  • Patient reports presence/absence of headaches(Day 1)
  • Time spent snoring(Day 7)
  • Arousal index(Day 7)
  • Time in sleep stage(Day 7)
  • The periodic limb movement (PLM) index(Day 7)
  • List of concomitant medications(Day 1)
  • Epworth scale score(Day 7)
  • The Pittsburgh Sleep Quality Index (PSQI)(Day 7)
  • Respiratory Disturbance Index(Day 7)
  • The pain dimension of the EQ-5D-3L Questionaire (the 3-level version of Euroqol EQ-5D)(Day 1)
  • The visual analog scale from the EQ-5D-3L Questionaire (the 3-level version of Euroqol EQ-5D)(Day 1)
  • Hypopnea index(Day 7)
  • Apnea and Hypopnea index(Day 7)
  • Number of limb movements associated with respiratory events index(Day 7)
  • Photoplethysmography arousal index(Day 7)
  • The Karolinska questionnaire(Day 7)
  • The mobility dimension of the EQ-5D-3L Questionaire (the 3-level version of Euroqol EQ-5D)(Day 1)
  • The daily activities dimension of the EQ-5D-3L Questionaire (the 3-level version of Euroqol EQ-5D)(Day 1)
  • The anxiety-depression dimension of the EQ-5D-3L Questionaire (the 3-level version of Euroqol EQ-5D)(Day 1)
  • Total sleep time (TST)(Day 7)
  • Mixed apnea index(Day 7)
  • The Nasal Obstruction Symptom Evaluation (NOSE) questionnaire(Day 7)
  • Obstructive apnea index(Day 7)
  • Apnea index(Day 7)
  • Time below 90% SpO2(Day 7)
  • Mean SpO2(Day 7)
  • PLM arousal(Day 7)
  • For asthma patients, the GINA control score(Day 1)
  • The Allergic Rhinitis Control Test (ARCT) rhinitis questionnaire(Day 1)
  • Respiratory effort related arousal index(Day 7)
  • Oxygen desaturation ≥ 3% index(Day 7)
  • Sleep Onset Latency(Day 7)
  • Percentage of sleep efficiency(Day 7)
  • Respiratory fragmentation of sleep index(Day 7)
  • ARIA rhinitis classification(Day 1)
  • Minimal SpO2 during sleep(Day 7)
  • Time in bed(Day 7)
  • Sleep Latency(Day 7)
  • Random eye movement (REM) stage latency(Day 7)
  • Percent of TST in sleep stage(Day 7)
  • Arousal index associated with respiratory events(Day 7)
  • TST(Day 7)
  • WASO(Day 7)
  • % of TST spent in respiratory effort(Day 7)
  • Fragmentation of sleep index(Day 7)
  • Presence/absence of asthma(Day 1)
  • Forced expiratory volume in 1 second, % predicted(Day 1)
  • Forced expiratory volume 25-75, % predicted predicted(Day 1)
  • Patient reports presence/absence of poor sleep(Day 1)
  • Patient reports presence/absence of snoring(Day 1)
  • % of TST below 90% of SpO2(Day 7)
  • Wake After Sleep Onset (WASO)(Day 7)
  • Forced expiratory volume in 1 second / Forced vital capacity (% litres/litres)predicted(Day 1)
  • Patient reports presence/absence of dry mouth(Day 1)
  • Antecedent of public road or work accident (yes/no)(Day 1)
  • Allergen prick test results(Day 1)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验